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In order to devise long-lived, functional implants, it is necessary that the material from which the implant is derived does not conjure destructive immune responses. Innate immune mechanisms, including acute and chronic inflammation and the ensuing foreign body reaction,
dictate whether or not biointegration is successful. Thus, when designing biomaterials, it is imperative to cater to known physiological processes which will not trigger undesirable immunological outcomes, but rather support healing processes. This process, called biointegration,
involves a seamless physical interconnection between biomaterial and recipient tissue. Many patients who undergo implantation fail to achieve biointegration, cascading to epithelial downgrowth and bacterial infection, subsequent device failure and removal, and in, rare
circumstances, sepsis. With this in mind, there exists a pressing need to further optimize modern implants in order to maintain device stability, efficacy, and safety. Because the interaction of host tissue with the biomaterial occurs largely at the material surface, modulation of
surface chemistry is an enticing means for improving biointegration. Here, we generated microporous, PDMS bioscaffolds with altered surface chemistries as a model to assess how well modified implants may assuage host immunity in vitro. Following surface treatment with
polydopamine (PDA) alone or PDA + TiO2—both promising surface modifications for improving implant outcome—, scaffolds were cultured with either macrophages (MΦ), dermal fibroblasts (DF), or mesenchymal stem cells (MSC) to elucidate how these surface chemistries may
either promote or obstruct successful implantation. Understanding how specific surface chemistry modifications like these dictate innate immune mechanisms and wound healing processes will help inform future design of future immunomodulatory biomaterials.






PDMS Scaffold Fabrication –
Surface Modification and Characterization – Untreated PDMS discs were immersed in
a dilute, aqueous solution of dopamine (2 mg/ml dopamine in 10 mM Tris buffer, pH 8.5)
for 24 h with light shaking to generate a layer of PDA. After a thorough wash with
deionized water, the PDA-coated sponges were immersed in 0.1M ammonium
hexafluorotitanate ((NH4)2TiF6) and 0.3M boric acid (H3BO3) solution at pH 3.9 overnight
on a shaker at room temperature to result in TiO2 coating.
Cell Culture and Seeding – MSCs, DF, and monocytes were cultured in T75 flasks in the
proper medium, prior to seeding onto scaffolds in a 24-well plate. All cells types were
incubated at 37°C in a 5% CO2 environment. Monocytes were allowed to differentiate
into MΦ for 7 days prior to seeding. Seeding densities were as follows (cells/well): MSC
5.7x103; DF 1.9x104; MΦ 1.6x104.
Enzyme-Linked Immunosorbent Assay – ELISAs were performed using kits from
Boster Immunoleader. For this measurement, the medium added to cells was collected
from each well after 24 h. These samples were centrifuged at 1000 rcf for 5 min and the
supernatant was collected for cytokine analysis. For a positive control, one set of cells
(N=4) per cell type was spiked with bacterial lipopolysaccharide (LPS) at a concentration
of 0.2 ng/mL.
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Figure 3. Energy dispersive
x-ray spectroscopy (EDX) of
surface-treated scaffold.
Many elements present in
the spectrum, such as Au,
Si, C, and Pd, result from
Au/Pd coating for SEM.
There is a peak at Ti
demonstrating that coating
was successful.
Figure 4. X-ray photo electron
spectroscopy (XPS) of surface-treated
scaffold. This demonstrates the
oxidation state of deposited metal on
the scaffold surface (e.g., whether it is
metallic Ti, for example, or metal oxide
(TiO2). Here, there is a peak at TiO2.
Figure 1. Macrophages are the driving force of chronic inflammation (adapted
from X. Wang, 2013).
Figure 2. Scanning electron microscopy (SEM) images of microporous scaffolds with
altered surface chemistries and varying porosities.
Figure 5. (Above Left.) A chart
illustrating the role of cytokines in
the foreign body reaction
(adapted from Brodbeck et al.
2013). Figure 6. (Above right.)
DF proliferation in response to
PDMS. Figure 7. (Left.)
Production of pro-inflammatory
cytokine TNF-α by macrophages
in presence of scaffolds.
Here, we have established a successful mechanism for generating microporous, PDMS
scaffolds with altered surface chemistries—including deposition of PDA and TiO2—as a
model for characterizing success of implant biointegration.
TiO2 coating on PDMS results a marked decrease in production of the pro-inflammatory
cytokine tumor necrosis factor α in macrophages, making it a suitable candidate for
biomaterial modification.
In the future, a larger panel of cytokines, including those vital for both wound healing and
inflammation, must be assessed. DF and MSC proliferation and adherence to these
scaffolds should also be examined. Lastly, in vivo experimentation is necessary to
examine overall tissue reaction to implantation.
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